ND

Ningthoujam Daina Chanu

Active Director Director DIN 09220769
DIN 09220769 First appointment Jul 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Total affiliations 4 Since Jul 2021
Shareholding value •••• Premium profile

About Ningthoujam Daina Chanu

Data last updated:

Ningthoujam Daina Chanu is a Director at Lamjingba Hospital And Medical Research Institute Private Limited (since 2022), Additional Director at Sayon Transport Private Limited (since 2021) and Additional Director at Sayon Industries Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Healthcare, Transportation and Chemicals. The 4 current companies with reported revenue have a combined latest revenue of ₹1.91 Cr; the largest is Lamjingba Hospital And Medical Research Institute Private Limited at ₹84.9 Lakh (FY 2020).

DIN 09220769
Primary Designation Director
Industry Healthcare
First Appointment 22 Jul 2021
Oldest Company Age 7 yrs
Combined revenue ₹1.91 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Jun 20222018₹84.9 Lakh (FY 2020)Active
Sayon Transport Private Limited U60221MN2020PTC014158
Additional Director22 Jul 20212020₹51.6 Lakh (FY 2021)Active
Sayon Industries Private Limited U24299MN2019PTC013971
Additional Director22 Jul 20212019₹37.6 Lakh (FY 2022)Active
Additional Director27 Aug 20222019₹16.8 Lakh (FY 2020)Active

Directorship timeline

Open interactive timeline →
Sayon Industries Private Limited
Sayon Transport Private Limited
Lamjingba Hotel And Resorts Private Limited
Lamjingba Hospital And Medical Research Institute Private Limited
Premium access

Shareholding and investment profile for Ningthoujam Daina Chanu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ningthoujam Daina Chanu

Ningthoujam Daina Chanu currently holds 4 directorships: Lamjingba Hospital And Medical Research Institute Private Limited (Director, since 13 Jun 2022, revenue ₹84.9 Lakh (FY 2020)); Sayon Transport Private Limited (Additional Director, since 22 Jul 2021, revenue ₹51.6 Lakh (FY 2021)); Sayon Industries Private Limited (Additional Director, since 22 Jul 2021, revenue ₹37.6 Lakh (FY 2022)); Lamjingba Hotel And Resorts Private Limited (Additional Director, since 27 Aug 2022, revenue ₹16.8 Lakh (FY 2020)).

Ningthoujam Daina Chanu was first appointed on 22 Jul 2021 as Additional Director at Sayon Transport Private Limited. The most recent appointment on record is 27 Aug 2022 at Lamjingba Hotel And Resorts Private Limited.

The 4 current companies of Ningthoujam Daina Chanu that report revenue have a combined latest revenue of ₹1.91 Cr: Lamjingba Hospital And Medical Research Institute Private Limited ₹84.9 Lakh (FY 2020); Sayon Transport Private Limited ₹51.6 Lakh (FY 2021); Sayon Industries Private Limited ₹37.6 Lakh (FY 2022); Lamjingba Hotel And Resorts Private Limited ₹16.8 Lakh (FY 2020).

The current boards of Ningthoujam Daina Chanu's companies include Inaoton Laiphrakpam (Lamjingba Hospital And Medical Research Institute Private Limited), Irengbam Priyokumar Singh (Lamjingba Hospital And Medical Research Institute Private Limited), Mutum Robindro Singh (Lamjingba Hospital And Medical Research Institute Private Limited), Laishubam Rocky Singh (Sayon Transport Private Limited), Laishram Bisheshwor Meitei (Sayon Industries Private Limited), Mutum Byron Singh (Lamjingba Hotel And Resorts Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available